Loading...
Loading chart...



The current price of FORA is 2.1 USD — it has increased 0
Forian Inc. is a healthtech company. The Company is a provider of data science-driven information and analytics solutions to the life science, healthcare and financial services industries. It provides a suite of data management capabilities and proprietary information and analytics solutions to optimize and measure the operational, clinical and financial performance of customers. The Company has expertise in acquiring, integrating, normalizing and commercializing large-scale healthcare data assets. The Company’s offerings include commercial, Real World Evidence (RWE) and market access solutions and proprietary data-driven insights to optimize the operational, clinical and financial performance of its customers. Its solutions include CHRONOS, Chartis, RWE and Kyber Data Science. CHRONOS, combines open and closed claims, electronic health records, and social determinants of health data into a single, integrated model.
Wall Street analysts forecast FORA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for FORA is2.10 USD with a low forecast of 2.10 USD and a high forecast of 2.10 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Forian Inc revenue for the last quarter amounts to 7.76M USD, increased 65.64
Forian Inc. EPS for the last quarter amounts to -0.00 USD, decreased -100.00
Forian Inc (FORA) has 1 emplpoyees as of February 16 2026.
Today FORA has the market capitalization of 65.25M USD.